Imaging astrocytosis with pet in Creutzfeldt-Jakob disease: Case report with histopathological findings

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 2, 2012, Pages 201-207

  Engler, Henry ^a,b,c,f   Nennesmo, Inger ^d   Kumlien, Eva ^d   Gambini, Juan Pablo ^b   Lundberg, Po ^d   Savitcheva, Irina ^d   Långström, Bengt ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Nuclear Medicine   (Uruguay)

^c Faculty of Sciences   (Uruguay)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f CUDIM   (Uruguay)

Author keywords

Astrocytosis; CJD; Histopathology; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLIAL FIBRILLARY ACIDIC PROTEIN; N METHYL DEUTERODEPRENYL C 11; PRION PROTEIN; PRION RESISTANT PROTEIN; PROTEIN ANTIBODY; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTOSIS; AUTOPSY; BRAIN TISSUE; CASE REPORT; CODON; CREUTZFELDT JAKOB DISEASE; DEATH; GENETIC ANALYSIS; GLUCOSE TRANSPORT; HEMISPHERE; HISTOPATHOLOGY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR GENETICS; NERVE CELL NECROSIS; POSITRON EMISSION TOMOGRAPHY; WESTERN BLOTTING;

EID: 84860000584     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ekblom J, Aquilonius SM, Jossan SS. Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis. Exp Neu-rol 1993; 123: 289-294.
2. Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H, Aquilonius SM, Bjurling P, Halldin C, Hartyig P, Leenders KL, Lundqvist H, Oreland L, Stalnacke C-G, Langstrom B. Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 1987; 235: 481-485.
3. Jossan SS, d'Argy R, Gillberg PG, Aquilonius SM, Langstrom B, Halldin C, Bjurling P, Stålnacke C-G, Fowler J, MacGregor R, Oreland L. Localization of monoamine oxidase B in human brain by autoradiographical use of 11C-labelled L-deprenyl. J Neural Transm 1989; 77: 55-64.
4. Jossan SS, Gillberg PG, d'Argy R, Aquilonius SM, Langstrom B, Halldin C, Oreland L. Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H] deprenyl. Brain Res 1991; 547: 69-76.
5. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H. Expression of monoamine oxidase B activity in astro-cytes of senile plaques. Acta Neuropathol 1990; 80: 419-425.
6. Stenstrom A, Arai Y, Oreland L. Intra- and extra-neuronal monoamineoxidase-A and -B activities after central axotomy (hemisection) on rats. J Neural Transm 1985; 61: 105-113.
7. Alavi A, Dann R, Chawluk J, Alavi J, Kushner M, Reivich M. Positron emission tomography imaging of regional cerebral glucose metabolism. Semin Nucl Med 1986; 16: 2-34.
8. Handforth A, Cheng JT, Mandelkern MA, Treiman DM. Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus. Epilepsia 1994; 35: 876-881.
9. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergstrom M, Tsukada H, Hartvig P, Långström B. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imaging 2003; 30: 85-95.
10. Fowler JS, Wolf AP, MacGregor RR, Dewey SL, Logan J, Schlyer DJ, Langstrom B. Mechanistic positron emission tomography studies: demonstration of deuterium isotope effect in the mono-amine oxidase-catalyzed binding of [11C]L-deprenyl in living baboon brain. J Neurochem 1988; 51: 1524-1534.
11. MacGregor RR, Fowler JS, Wolf AP, Halldin C, Langström B. Synthesis of suicide inhibitors of monoamine oxidase: carbon-11 labeled clor-gyline, L-deprenyl and D-deprenyl. J Labelled Comp Radiopharm 1988; 25: 1-9.
12. Bergström M, Kumlien E, Lilja A, Tyrefors N, Westerberg G, Långström B. Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl-analysis of kinetic data. Acta Neurol Scand 1998; 98: 224-231.
13. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shino-hara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurohem 1977; 28: 897-916.
14. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.
15. Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Långström B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 2008; 35: 100-106.
16. Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008; 29: 1456-1465.
17. Klunk WE, Engler H, Nordberg A, Wang Y, Blom-qvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
18. Andersson JL, Thurfjell L. Implementation and validation of a fully automatic system for intra-and interindividual registration of PET brain scans. J Comput Assist Tomogr 1997; 21: 136-144.
19. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple- time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
20. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shino-hara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neuro-chem 1977; 28: 897-916.
21. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979; 6: 371-388.